These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 17606894)

  • 21. Frontal assessment battery to evaluate frontal lobe dysfunction in ALS patients.
    Ahn SW; Kim SH; Kim JE; Kim SM; Kim SH; Sung JJ; Lee KW; Hong YH
    Can J Neurol Sci; 2011 Mar; 38(2):242-6. PubMed ID: 21320827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neuropsychological assessment in amyotrophic lateral sclerosis].
    Havet V
    Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S151-4S157. PubMed ID: 17128104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frontal Assessment Battery (FAB) is a simple tool for detecting executive deficits in chronic cannabis users.
    Fontes MA; Bolla KI; Cunha PJ; Almeida PP; Jungerman F; Laranjeira RR; Bressan RA; Lacerda AL
    J Clin Exp Neuropsychol; 2011 Jun; 33(5):523-31. PubMed ID: 21229432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Speech, expressive language, and verbal cognition of preschool children with cerebral palsy in Iceland.
    Sigurdardottir S; Vik T
    Dev Med Child Neurol; 2011 Jan; 53(1):74-80. PubMed ID: 21039439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen: a cross-sectional comparison of established screening tools in a German-Swiss population.
    Lulé D; Burkhardt C; Abdulla S; Böhm S; Kollewe K; Uttner I; Abrahams S; Bak TH; Petri S; Weber M; Ludolph AC
    Amyotroph Lateral Scler Frontotemporal Degener; 2015 Mar; 16(1-2):16-23. PubMed ID: 25292386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Dementia in amyotrophic lateral sclerosis].
    Gredal O; Nielsen K; Tarp T; Ehrenfels S
    Ugeskr Laeger; 2008 Oct; 170(42):3324-7. PubMed ID: 18940168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Writing errors as a result of frontal dysfunction in Japanese patients with amyotrophic lateral sclerosis.
    Tsuji-Akimoto S; Hamada S; Yabe I; Tamura I; Otsuki M; Kobashi S; Sasaki H
    J Neurol; 2010 Dec; 257(12):2071-7. PubMed ID: 20658298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The application of dysarthria profile tests in ALS patients for the detection of speech disturbances].
    Tomik B; Głodzik-Sobańska L; Lechwacka A; Bała-Słodowska M; Kolasa M; Szczudlik A
    Neurol Neurochir Pol; 2000; 34(2):269-79. PubMed ID: 10962720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive screening in patients with amyotrophic lateral sclerosis in early stages.
    Floris G; Borghero G; Chiò A; Secchi L; Cannas A; Sardu C; Calvo A; Moglia C; Marrosu MG
    Amyotroph Lateral Scler; 2012 Jan; 13(1):95-101. PubMed ID: 21895509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Speech, language, and cognition in preschool children with epilepsy.
    Selassie GR; Viggedal G; Olsson I; Jennische M
    Dev Med Child Neurol; 2008 Jun; 50(6):432-8. PubMed ID: 18422681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Depression and frontal dysfunction: risks for the elderly?].
    Thomas P; Hazif Thomas C; Billon R; Peix R; Faugeron P; Clément JP
    Encephale; 2009 Sep; 35(4):361-9. PubMed ID: 19748373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Neuropsychological disorders in amyotrophic lateral sclerosis. Don't they exist or do they just go undetected?].
    Duque P; Páramo MD; Borges M; Peral E; García Moreno JM; Balarezo L; Izquierdo G; Sanchez López F; Patrignani Ochoa JH
    Rev Neurol; 2003 Jan 1-15; 36(1):3-8. PubMed ID: 12577205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of augmentative communication devices in the medical management of ALS.
    Brownlee A; Palovcak M
    NeuroRehabilitation; 2007; 22(6):445-50. PubMed ID: 18198430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychosocial factors and cognition in amyotrophic lateral sclerosis.
    Grossman A; Bradley W
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Dec; 4(4):217-24. PubMed ID: 14753655
    [No Abstract]   [Full Text] [Related]  

  • 35. Cognitive impairment, frontotemporal dementia, and the motor neuron diseases.
    Strong MJ; Lomen-Hoerth C; Caselli RJ; Bigio EH; Yang W
    Ann Neurol; 2003; 54 Suppl 5():S20-3. PubMed ID: 12833364
    [No Abstract]   [Full Text] [Related]  

  • 36. The UCSF screening exam effectively screens cognitive and behavioral impairment in patients with ALS.
    Murphy J; Ahmed F; Lomen-Hoerth C
    Amyotroph Lateral Scler Frontotemporal Degener; 2015 Mar; 16(1-2):24-30. PubMed ID: 25301548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive and behavioral impairment in amyotrophic lateral sclerosis.
    Woolley SC; Jonathan S Katz
    Phys Med Rehabil Clin N Am; 2008 Aug; 19(3):607-17, xi. PubMed ID: 18625419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonstandardized assessment approaches for individuals with traumatic brain injuries.
    Coelho C; Ylvisaker M; Turkstra LS
    Semin Speech Lang; 2005 Nov; 26(4):223-41. PubMed ID: 16278795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Speech therapy guidelines in patients with amyotrophic lateral sclerosis].
    Lévêque N
    Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S269-4S272. PubMed ID: 17128123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frontal Anatomical Correlates of Cognitive and Speech Motor Deficits in Amyotrophic Lateral Sclerosis.
    Yunusova Y; Ansari J; Ramirez J; Shellikeri S; Stanisz GJ; Black SE; Gillingham SM; Kiss A; Stuss DT; Zinman L
    Behav Neurol; 2019; 2019():9518309. PubMed ID: 31001362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.